Professor Colin Dayan



Prosiectau fel Prif Ymchwiliwr
null null 6 o 7 null null

Morbidity and Mortality in Liothyronine treated patients: LT3 Outcome study - Cyllidwr:British Thyroid Foundation (01.06.2018 - 31.05.2021)
EFSD Mentorship Programme - Cyllidwr:European Foundation for the Study of Diabetes (01.01.2019 - 31.12.2021)
IMCY-T1D-002: Long term follow-up study of T1D patients previously treated with IMCY-0098 or placebo - Cyllidwr:Cardiff & Vale University Health Board (19.03.2019 - 31.03.2020)
Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger smarter faster - Cyllidwr:Juvenile Diabetic Research Foundation (01.05.2019 - 30.04.2022)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 3 null null

Microneedle delivery of antigen-specific immunotherapy for type 1 diabetes - Cyllidwr:Engineering and Physical Sciences Research Council (01.10.2014 - 30.09.2018)
B cells in newly diagnosed type 1 diabetes - Cyllidwr:Diabetes UK (01.03.2012 - 31.07.2016)
Peptide-HLA multimers as biomarkers of autoimmune disease - Cyllidwr:Wellcome Trust (01.07.2012 - 31.07.2014)

Diweddarwyd y tro diwethaf ar 2020-09-08 am 04:07